Expansion Therapeutics
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $73M
Investors
- 11
About Expansion Therapeutics
Founded in 2016 in Jupiter, US, Expansion Therapeutics specializes in RNA-targeting therapies.03 mn across 2 deals as it continues to develop its small molecule RNA platform.Expansion Therapeutics specializes in the development of transformative oral medicines that target RNA to address severe RNA-mediated diseases, particularly major neurological disorders. Central to their product offerings is the innovative platform focused on Small Molecules interacting with RNA (SMiRNA), which is based on foundational research by scientific founder Matt Disney.Expansion Therapeutics generates revenue primarily through partnerships and collaborations within the pharmaceutical and biotechnology sectors. The company engages in business-to-business transactions with healthcare institutions and pharmaceutical companies interested in its SMiRNA technology for therapeutic development. Expansion Therapeutics aims to launch new products targeting neurological diseases and plans to explore additional markets, with specific geographic expansion strategies to be announced as they progress.
Who invested in Expansion Therapeutics
11 investors across 2 rounds
See all investors in Expansion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Expansion Therapeutics
Who invested in Expansion Therapeutics?
Expansion Therapeutics has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Expansion Therapeutics raised?
Expansion Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Expansion Therapeutics last raise money?
Expansion Therapeutics's most recent round on record is a Series B, in Sep 2021.
What does Expansion Therapeutics do?
Founded in 2016 in Jupiter, US, Expansion Therapeutics specializes in RNA-targeting therapies.
Where is Expansion Therapeutics headquartered?
Expansion Therapeutics is headquartered in Jupiter, US.
Which VCs invest in companies like Expansion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Expansion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Expansion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.